Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Pacific Clinical Research Medical Group
mi
from
Orange, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Pacific Clinical Research Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
SMRI
mi
from
Sherman Oaks, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
SMRI
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Sarkis Clinical Trials
mi
from
Gainesville, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Florida Research Center
mi
from
Maitland, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Florida Research Center
mi
from
Maitland, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
University of Miami, Miller School
mi
from
Miami, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
University of Miami, Miller School
mi
from
Miami, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Miami Research
mi
from
Miami, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Miami Research
mi
from
Miami, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Hawaii Clinical Research Center
mi
from
Honolulu, HI
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Hawaii Clinical Research Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Psychiatric Medicine Associates
mi
from
Skokie, IL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Psychiatric Medicine Associates
mi
from
Skokie, IL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
CRI Worldwide
mi
from
Mt Laurel, NJ
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
CRI Worldwide
mi
from
Mt Laurel, NJ
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Montefiore Medical Center; Anxiety & Depression Clinic; Dept. of Psychiatry
mi
from
Bronx, NY
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Montefiore Medical Center; Anxiety & Depression Clinic; Dept. of Psychiatry
mi
from
Bronx, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Medical & Behavioral Health Research
mi
from
New York, NY
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
New Hope Clinical Research
mi
from
Hickory, NC
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
New Hope Clinical Research
mi
from
Hickory, NC
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Sooner Clinical Research
mi
from
Oklahoma City, OK
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Sooner Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Suburban Research Associates
mi
from
Media, PA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Harry Croft and Associates
mi
from
San Antonio, TX
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Harry Croft and Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
University of Texas Health Science Center
mi
from
San Antonio, TX
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Department of Psychiatry, University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Department of Psychiatry, University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Northwest Clinical Research Center
mi
from
East Seattle, WA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Northwest Clinical Research Center
mi
from
East Seattle, WA
Click here to add this to my saved trials
Behavioral and Affective Skills in Coping (BASIC) Open Trial
Behavioral and Affective Skills in Coping: Practice-Adapted Child Psychotherapy
Status: Enrolling
Updated:  11/9/2011
Judge Baker Children's Center
mi
from
Boston, MA
Behavioral and Affective Skills in Coping (BASIC) Open Trial
Behavioral and Affective Skills in Coping: Practice-Adapted Child Psychotherapy
Status: Enrolling
Updated: 11/9/2011
Judge Baker Children's Center
mi
from
Boston, MA
Click here to add this to my saved trials
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated:  11/9/2011
Syracuse University - CNY Medical Center
mi
from
Syracuse, NY
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated: 11/9/2011
Syracuse University - CNY Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated:  11/9/2011
Upstate Medical University
mi
from
Syracuse, NY
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated: 11/9/2011
Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #023
mi
from
Beverly Hills, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #023
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #017
mi
from
Encino, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #017
mi
from
Encino, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #021
mi
from
Garden Grove, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #021
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #025
mi
from
Newport Beach, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #025
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 009
mi
from
Orange, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 009
mi
from
Orange, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Research Institute #001
mi
from
Bonita Springs, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Research Institute #001
mi
from
Bonita Springs, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #015
mi
from
Fort Myers, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #015
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #005
mi
from
North Miami, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #005
mi
from
North Miami, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 061
mi
from
Orlando, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #004
mi
from
South Miami, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #004
mi
from
South Miami, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Atlanta, GA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 071
mi
from
Prairie Village, KA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 071
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Portland, OR
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #008
mi
from
Bridgeville, PA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #008
mi
from
Bridgeville, PA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #028
mi
from
Norristown, PA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #028
mi
from
Norristown, PA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Memphis, TN
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 062
mi
from
San Antonio, TX
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 062
mi
from
San Antonio, TX
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Bellevue, WA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #027
mi
from
Seattle, WA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #027
mi
from
Seattle, WA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 007
mi
from
San Diego, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 007
mi
from
San Diego, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #029
mi
from
Maitland, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #029
mi
from
Maitland, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Chicago, IL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Baltimore, MD
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Baltimore, MD
Click here to add this to my saved trials